T1	Participants 218 302	behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years
T2	Participants 312 389	Phase 1 involved 65 children with ASD who received one round of DMSA (3 days)
T3	Participants 391 450	Participants who had high urinary excretion of toxic metals
T4	Participants 504 567	49 participants were randomly assigned in a double-blind design
T5	Participants 637 753	The groups receiving one round and seven rounds of DMSA had significant improvements on all the assessment measures.
T6	Participants 1315 1471	safe in children with ASD who have high urinary excretion of toxic metals, and possibly helpful in reducing some of the symptoms of autism in those children
